BioSpace News Archive

OliX Pharmaceuticals , Inc. (KOSDAQ: 226950), a key player in the development of RNAi therapeutics, today announced that Dong-Ki Lee, Ph.D., founder and Chief Executive Officer presented the Company’s platform technology and discussed the potential utility of siRNA therapeutics in combatting COVID-19 at BIO KOREA 2020 . During his session, “RNAi therapeutics against COVID-19,” Dr. Lee shared strategies to develop COVID-19 viru

Quest Analytics, the leader in measuring, managing and monitoring health plan network performance, announced today that it has named Steve Levin as Chief Executive Officer, effective immediately

FORCE Communications announced the creation of a visual depiction of the SARS-CoV-2 life cycle, which describes opportunities for the development of drugs and vaccines to treat and prevent coronavirus disease 2019 (COVID-19)

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 1,943,636 shares of its common stock, at a purchase price of $2.5725 per share, in a registered direct offering priced at-the-market under Nasd

Texas Children’s Hospital announces it will build a freestanding hospital in Austin to meet Central Texas families’ needs

Publication Demonstrates Ability of Sera Prognostics’ PreTRM ® Biomarker Test as a Predictor of Adverse Pregnancy Outcomes - New data published in American Journal of Obstetrics & Gynecology Maternal Fetal Medicine further support potential use of PreTRM ® to identify pregnancies that may benefit from preterm birth preventive strategies -

Building on its earlier reveal at the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG) today launched its Targeted Gene Expression Solution for single cell and shortly following for spatial genomic research.

Health plan expedites access to care and provides additional support to its Medicare members

BIOQUAL announces the release of two research publications in Science Magazine of our non-human primate model development efforts and our first successful testing of a COVID-19 vaccine candidate

SOLIUS is a biotechnology company that aims to improve health for people affected by conditions scientifically correlated with a reduction in sun exposure and vitamin D deficiency.